Cochrane Abstracts
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Non‐absorbable Disaccharides Versus Placebo/no Intervention and Lactulose Versus Lactitol for the Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Publication_bias_in_clinical_trials_due_to_statistical_significance_or_direction_of_trial_results_Unchanged. Accessed 19 April 2024.
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Publication_bias_in_clinical_trials_due_to_statistical_significance_or_direction_of_trial_results_Unchanged. Accessed April 19, 2024.
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Publication_bias_in_clinical_trials_due_to_statistical_significance_or_direction_of_trial_results_Unchanged
Non‐absorbable Disaccharides Versus Placebo/no Intervention and Lactulose Versus Lactitol for the Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Publication_bias_in_clinical_trials_due_to_statistical_significance_or_direction_of_trial_results_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
ID - 434060
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Publication_bias_in_clinical_trials_due_to_statistical_significance_or_direction_of_trial_results_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -
